China's largest biomedicine base — 1,300+ companies, the ‘1+4+4’ regulatory service system, 24 industry funds (~¥20B) and the ‘113’ talent program. CoreMedEco AI matches your project to the right city and incentives, with sources.
Quantitatively compare 9 regions on industry fit, incentives, logistics and Korean community infrastructure based on your criteria.
China-Korea industrial parks, RCEP, free-trade zones and more — every record links to its official source. Official documents always prevail.
Chat your way through company profile and requirements; the AI generates a full diagnosis report with reasoning you can cite.
Local investment-promotion bureaus review your profile and reference AI opinions to prioritize outreach — a two-sided structure.
Company name, industry, size and investment plan.
Rank your priorities: policy, cost, logistics or talent.
Receive ranked results with reasoning and confidence.
Compile cited opinions into a report; connect expert verification.
China's only national-level high-tech zone dedicated to pharmaceuticals, hosting 1,300+ medical companies. It offers full-cycle support: a provincial drug-regulator branch with the ‘1+4+4’ regulatory service system, 24 industry funds (~¥20B), and the ‘113’ medical talent program.
The ‘113’ medical talent program (381 projects, 2,059 specialists recruited), drug and device registration support via the ‘1+4+4’ regulatory system, investment access through 24 industry funds, and GMP manufacturing and R&D sites.
Enter your industry, investment size, top priority (policy, cost, logistics or talent) and preferred regions. The engine scores 9 regions on industry fit, incentives, logistics and Korean business infrastructure, and shows its reasoning and policy sources with every score.
Region matching and the AI diagnosis workspace are free. Registered cooperation projects receive a dedicated account for document upload, progress tracking and matchmaking with CMC departments.
Narrow down candidate regions with free region matching, then validate feasibility with an AI diagnosis.
Start region matching한국 기업의 자격과 소개를 검토하고 AI 매칭 의견을 참고해 우선 유치 기업을 선별합니다. 政府专用门户请登录后使用。
Government portal